What dose of Solu‑Medrol (methylprednisolone) should be administered to an adult with an acute ulcerative colitis flare?

Solu-Medrol Dosing for Acute Severe Ulcerative Colitis

For hospitalized adults with acute severe ulcerative colitis, administer intravenous methylprednisolone 40-60 mg daily rather than higher doses. 1

Recommended Dosing Regimen

• Standard dose: 40-60 mg/day of IV methylprednisolone administered as a single daily dose or divided doses 1
• Duration: 3-5 days is the typical trial period to assess response 1
• Maximum duration: Do not continue beyond 7 days if the patient is not responding, as prolonged therapy beyond this point has not shown benefit 1

Evidence Supporting This Dose Range

The 2020 AGA guidelines provide the strongest evidence for this dosing strategy. A systematic review by Turner et al. found that mean methylprednisolone doses in ASUC trials were 68 mg/day (range 40-100 mg), and meta-regression analysis demonstrated no correlation between higher corticosteroid doses and reduced colectomy risk after controlling for baseline disease severity (R²<0.01). 1, 2

The 2025 British Society of Gastroenterology guidelines corroborate this approach, noting that doses exceeding 40-60 mg/day provide no additional benefit and potentially increase adverse effects. 1

Administration Details

• Route: Intravenous injection or infusion preferred for initial emergency management 3
• Infusion rate: Administer over several minutes for standard doses 3
• Safety warning: Doses >500 mg given over <10 minutes carry risk of cardiac arrhythmias and arrest 3

Clinical Decision Points

Day 3 assessment is critical:

• Evaluate clinical response (stool frequency, blood in stool, systemic signs) 1
• If no improvement by day 3-5, initiate rescue therapy with infliximab or cyclosporine rather than continuing steroids 1, 4
• Predictors of steroid failure include: extensive disease, stool frequency >8/day, fever, tachycardia, elevated CRP, low albumin, and concerning radiologic findings 2

Common Pitfalls to Avoid

• Do not use higher doses (>60 mg/day): No evidence supports improved efficacy, and adverse effects increase 1, 2
• Do not prolong therapy beyond 7 days in non-responders: This delays appropriate rescue therapy or surgery without benefit 1
• Do not use corticosteroids for maintenance therapy: They are for induction only 1

Comparison with Hydrocortisone

While some centers use IV hydrocortisone 100 mg four times daily (400 mg/day total), recent data suggests methylprednisolone may require more frequent rescue therapy (36.4% vs 19.6% with hydrocortisone, OR 2.79), though it causes less hypokalemia (55.8% vs 67.0%). 5 The AGA guidelines focus on methylprednisolone equivalents as the reference standard. 1

Transition to Oral Therapy

Once clinical response is achieved:

• Switch to oral prednisolone 40 mg/day 1, 6
• Taper by 5 mg/week is most common, though practice varies 6
• Initiate steroid-sparing maintenance therapy (biologics, immunomodulators, or JAK inhibitors) rather than continuing corticosteroids long-term 1